Koninklijke Philips (NYSE:PHG) Shares Gap Down to $26.19

Koninklijke Philips (NYSE:PHG) gapped down prior to trading on Tuesday . The stock had previously closed at $26.19, but opened at $25.65. Koninklijke Philips shares last traded at $25.58, with a volume of 93,710 shares.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on PHG shares. BNP Paribas upgraded shares of Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday, May 7th. JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a research note on Monday, May 13th. UBS Group raised shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a research note on Tuesday, April 30th. Finally, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Friday, May 24th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Koninklijke Philips has an average rating of “Moderate Buy” and an average price target of $19.00.

Koninklijke Philips Trading Up 1.4 %

The stock’s 50 day moving average is $25.66 and its two-hundred day moving average is $22.93. The company has a market capitalization of $23.39 billion, a PE ratio of -26.87, a price-to-earnings-growth ratio of 0.84 and a beta of 0.76. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Monday, April 29th. The technology company reported $0.28 EPS for the quarter. The business had revenue of $4.49 billion during the quarter. Koninklijke Philips had a negative net margin of 4.41% and a positive return on equity of 9.82%. As a group, sell-side analysts predict that Koninklijke Philips will post 1.54 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which was paid on Thursday, May 9th. Shareholders of record on Friday, May 10th were given a dividend of $0.9154 per share. This represents a dividend yield of 3.5%. The ex-dividend date was Thursday, May 9th. Koninklijke Philips’s payout ratio is -95.83%.

Institutional Trading of Koninklijke Philips

Hedge funds have recently modified their holdings of the company. Capital Analysts LLC increased its holdings in Koninklijke Philips by 6.3% in the 4th quarter. Capital Analysts LLC now owns 8,820 shares of the technology company’s stock worth $206,000 after buying an additional 521 shares during the period. Dorsey & Whitney Trust CO LLC increased its holdings in Koninklijke Philips by 5.7% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 11,374 shares of the technology company’s stock worth $265,000 after buying an additional 615 shares during the period. Fifth Third Bancorp increased its holdings in Koninklijke Philips by 34.4% in the 1st quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after buying an additional 770 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Koninklijke Philips by 13.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 7,534 shares of the technology company’s stock worth $151,000 after buying an additional 897 shares during the period. Finally, Bank of New Hampshire increased its holdings in Koninklijke Philips by 0.8% in the 4th quarter. Bank of New Hampshire now owns 117,280 shares of the technology company’s stock worth $2,736,000 after buying an additional 908 shares during the period. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.